CLDN1 and colorectal carcinoma: For example, the regulatory role of CLDN1 in chemoresistance has been proven for several malignancies, including colorectal cancer (CRC) [28] and lung adenocarcinoma [29,30], thereby suggesting that CLDN1 expression in human malignancies may serve as a predictive marker of chemosensitivity.